• Veru Provides FDA Update on Request for Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDS

    ソース: Nasdaq GlobeNewswire / 02 3 2023 16:01:00   America/New_York

    N/A
シェアする